300 related articles for article (PubMed ID: 38318325)
61. A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.
Perreault S; Larouche V; Tabori U; Hawkin C; Lippé S; Ellezam B; Décarie JC; Théoret Y; Métras MÉ; Sultan S; Cantin É; Routhier MÈ; Caru M; Legault G; Bouffet É; Lafay-Cousin L; Hukin J; Erker C; Jabado N
BMC Cancer; 2019 Dec; 19(1):1250. PubMed ID: 31881853
[TBL] [Abstract][Full Text] [Related]
62. The molecular and cell biology of pediatric low-grade gliomas.
Chen YH; Gutmann DH
Oncogene; 2014 Apr; 33(16):2019-26. PubMed ID: 23624918
[TBL] [Abstract][Full Text] [Related]
63. Further understanding of the pathology of glioma: implications for the clinic.
Camelo-Piragua S; Kesari S
Expert Rev Neurother; 2016 Sep; 16(9):1055-65. PubMed ID: 27228211
[TBL] [Abstract][Full Text] [Related]
64. Classification and Treatment of Pediatric Gliomas in the Molecular Era.
Hauser P
Children (Basel); 2021 Aug; 8(9):. PubMed ID: 34572171
[TBL] [Abstract][Full Text] [Related]
65. Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.
Lo HW
Curr Cancer Drug Targets; 2010 Dec; 10(8):840-8. PubMed ID: 20718706
[TBL] [Abstract][Full Text] [Related]
66. Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database.
Bandopadhayay P; Bergthold G; London WB; Goumnerova LC; Morales La Madrid A; Marcus KJ; Guo D; Ullrich NJ; Robison NJ; Chi SN; Beroukhim R; Kieran MW; Manley PE
Pediatr Blood Cancer; 2014 Jul; 61(7):1173-9. PubMed ID: 24482038
[TBL] [Abstract][Full Text] [Related]
67. Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas.
Juratli TA; Qin N; Cahill DP; Filbin MG
Pharmacol Ther; 2018 Feb; 182():70-79. PubMed ID: 28830841
[TBL] [Abstract][Full Text] [Related]
68. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
69. Contemporary Mouse Models in Glioma Research.
Hicks WH; Bird CE; Traylor JI; Shi DD; El Ahmadieh TY; Richardson TE; McBrayer SK; Abdullah KG
Cells; 2021 Mar; 10(3):. PubMed ID: 33806933
[TBL] [Abstract][Full Text] [Related]
70. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
71. Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.
Nobre L; Zapotocky M; Ramaswamy V; Ryall S; Bennett J; Alderete D; Balaguer Guill J; Baroni L; Bartels U; Bavle A; Bornhorst M; Boue DR; Canete A; Chintagumpala M; Coven SL; Cruz O; Dahiya S; Dirks P; Dunkel IJ; Eisenstat D; Faure Conter C; Finch E; Finlay JL; Frappaz D; Garre ML; Gauvain K; Bechensteen AG; Hansford JR; Harting I; Hauser P; Hazrati LN; Huang A; Injac SG; Iurilli V; Karajannis M; Kaur G; Kyncl M; Krskova L; Laperriere N; Larouche V; Lassaletta A; Leary S; Lin F; Mascelli S; McKeown T; Milde T; Morales La Madrid A; Morana G; Morse H; Mushtaq N; Osorio DS; Packer R; Pavelka Z; Quiroga-Cantero E; Rutka J; Sabel M; Salgado D; Solano P; Sterba J; Su J; Sumerauer D; Taylor MD; Toledano H; Tsang DS; Valente Fernandes M; van Landeghem F; van Tilburg CM; Wilson B; Witt O; Zamecnik J; Bouffet E; Hawkins C; Tabori U
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923898
[TBL] [Abstract][Full Text] [Related]
72. Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites.
Solano-Páez P; Fonseca A; Baroni LV; Amayiri N; Somarriba MP; Freytes C; Quiroga E; Rivero M; Márquez J; Lassaletta Á; Bouffet E
J Neurooncol; 2022 Mar; 157(1):147-156. PubMed ID: 35122583
[TBL] [Abstract][Full Text] [Related]
73. Low-Grade Glioma Radiotherapy Treatment and Trials.
Wang TJC; Mehta MP
Neurosurg Clin N Am; 2019 Jan; 30(1):111-118. PubMed ID: 30470398
[TBL] [Abstract][Full Text] [Related]
74. CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles.
Jain P; Fierst TM; Han HJ; Smith TE; Vakil A; Storm PB; Resnick AC; Waanders AJ
Oncogene; 2017 Nov; 36(45):6348-6358. PubMed ID: 28806393
[TBL] [Abstract][Full Text] [Related]
75. Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy.
Graham MS; Mellinghoff IK
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003625
[TBL] [Abstract][Full Text] [Related]
76. Druggable genomic landscapes of high-grade gliomas.
Ghanem P; Fatteh M; Kamson DO; Balan A; Chang M; Tao J; Blakeley J; ; Canzoniero J; Grossman SA; Marrone K; Schreck KC; Anagnostou V
Front Med (Lausanne); 2023; 10():1254955. PubMed ID: 38143440
[TBL] [Abstract][Full Text] [Related]
77. Role of gamma knife radiosurgery in the management of intracranial gliomas.
Deora H; Tripathi M; Tewari MK; Ahuja CK; Kumar N; Kaur A; Kamboj P
Neurol India; 2020; 68(2):290-298. PubMed ID: 32415008
[TBL] [Abstract][Full Text] [Related]
78. Pediatric low-grade glioma in the era of molecular diagnostics.
Ryall S; Tabori U; Hawkins C
Acta Neuropathol Commun; 2020 Mar; 8(1):30. PubMed ID: 32164789
[TBL] [Abstract][Full Text] [Related]
79. Benign Glioma.
Wu PB; Filley AC; Miller ML; Bruce JN
Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
[TBL] [Abstract][Full Text] [Related]
80. Preclinical modeling of lower-grade gliomas.
Tang LW; Mallela AN; Deng H; Richardson TE; Hervey-Jumper SL; McBrayer SK; Abdullah KG
Front Oncol; 2023; 13():1139383. PubMed ID: 37051530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
